| Dr Erin E Jain, MD | |
|
2401 W Belvedere Ave, Baltimore, MD 21215-5216 | |
| (410) 601-5284 | |
| Not Available |
| Full Name | Dr Erin E Jain |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2401 W Belvedere Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043353766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | P20631 (Maryland) | Primary |
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Investigators in The Research Institute at Nationwide Children's Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).
Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.
The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.
The New York Times reports that young people — representing nearly one-third of the 46 million uninsured in America — stand to "reap substantial benefits" from expanded coverage for them in the new health law.
› Verified 2 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Investigators in The Research Institute at Nationwide Children's Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).
Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.
The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.
The New York Times reports that young people — representing nearly one-third of the 46 million uninsured in America — stand to "reap substantial benefits" from expanded coverage for them in the new health law.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin E Jain, MD 210 Bolton Pl, Baltimore, MD 21217-4105 Ph: (410) 499-7375 | Dr Erin E Jain, MD 2401 W Belvedere Ave, Baltimore, MD 21215-5216 Ph: (410) 601-5284 |
News Archive
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Investigators in The Research Institute at Nationwide Children's Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).
Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.
The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.
The New York Times reports that young people — representing nearly one-third of the 46 million uninsured in America — stand to "reap substantial benefits" from expanded coverage for them in the new health law.
› Verified 2 days ago
Hilary Tamara Wolf, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-7373 Fax: 410-328-7305 | |
Dr. Carmel Bogle, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 443-287-0526 Fax: 410-955-0897 | |
Anna Eunjoo Choe, Pediatrics Medicare: Medicare Enrolled Practice Location: 615 N Wolfe St Rm Wb602, Baltimore, MD 21205 Phone: 410-955-3362 Fax: 410-614-1582 | |
Dr. Melissa Lauren Shapiro, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2411 W Belvedere Ave Ste 407, Baltimore, MD 21215 Phone: 410-601-8663 | |
Dr. Alexander James Jaksic, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 781-223-0948 | |
Adam J Spanier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Armory Pl, Baltimore, MD 21201 Phone: 410-225-8780 Fax: 410-225-8766 | |
Milagritos D Tapia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6749 Fax: 410-328-6136 |